Results
4517
Companies which are more than 50% undervalued based on analyst price target.
4,517 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GEM | NOK 2.15 | -4.4% | -62.5% | NOK 32.2m | NOK 16.00 | PS5241.1x | E-49.9% | n/a | Materials | ||
AWH | US$0.17 | -24.7% | -95.9% | US$2.8m | US$5.50 | PS0.3x | S56.6% | n/a | Healthcare | ||
VINC | US$1.09 | -12.1% | -98.7% | US$2.8m | US$120.00 | PB0.3x | E-0.3% | n/a | Pharmaceuticals & Biotech | ||
THAR | US$1.43 | -24.7% | -75.8% | US$2.8m | US$5.00 | PB0.9x | E-23.1% | n/a | Pharmaceuticals & Biotech | ||
VTAK | US$0.35 | 0.9% | -93.0% | US$2.8m | US$2.00 | PS7x | E20.4% | n/a | Healthcare | ||
CNSP | US$2.43 | -24.8% | -99.7% | US$2.8m | US$112.50 | PB0.8x | E50.2% | n/a | Pharmaceuticals & Biotech | ||
SXTP | US$1.81 | -19.6% | -89.7% | US$2.8m | US$17.00 | PS5.8x | E-2.0% | n/a | Pharmaceuticals & Biotech | ||
YCBD | US$0.41 | -6.6% | -38.3% | US$2.7m | US$2.00 | PS0.1x | E95.3% | n/a | Pharmaceuticals & Biotech | ||
ACON | US$3.35 | -34.4% | -97.5% | US$2.7m | US$435.50 | PS69x | E7.5% | n/a | Healthcare | ||
NAYA | US$0.37 | -2.7% | n/a | US$2.6m | US$2.00 | PE-0.2x | E-33.1% | n/a | Healthcare | ||
CELL | CA$0.02 | -33.3% | -60.0% | CA$3.8m | CA$0.19 | PB0.6x | n/a | 10.0% | Materials | ||
CMOTEC B | SEK 1.21 | -1.6% | -55.0% | SEK 27.8m | SEK 3.10 | PS5.6x | E29.0% | n/a | Healthcare | ||
SMK | UK£0.035 | 0% | 40.0% | UK£2.0m | UK£0.81 | PS0.1x | n/a | n/a | Retail | ||
PCSA | US$0.55 | 3.6% | -77.7% | US$2.6m | US$6.00 | PB0.7x | E-5.7% | n/a | Pharmaceuticals & Biotech | ||
MAXENT B | SEK 0.50 | 28.6% | -83.5% | SEK 26.6m | SEK 1.15 | PS0.02x | E54.0% | n/a | Media | ||
GSR | €0.34 | -24.7% | -49.0% | €2.4m | €0.56 | PS1.2x | E106.5% | n/a | Real Estate Management and Development | ||
GLL | AU$0.007 | 16.7% | -81.1% | AU$3.9m | AU$0.03 | PB18.4x | n/a | n/a | Energy | ||
XPON | US$1.14 | -20.8% | -99.7% | US$2.4m | US$4.00 | PS0.5x | E75.7% | n/a | Capital Goods | ||
ATXI | US$1.10 | -19.1% | -90.7% | US$2.4m | US$8.00 | PB0.8x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
DRMA | US$1.14 | -8.8% | -83.3% | US$2.4m | US$6.00 | PB0.5x | E-14.0% | n/a | Pharmaceuticals & Biotech | ||
NDRA | US$4.33 | 0.007% | -99.8% | US$2.4m | US$2,625.00 | PB0.4x | E-16.8% | n/a | Healthcare | ||
ICON | US$0.22 | -24.9% | n/a | US$2.3m | US$1.25 | PE5.2x | S49.0% | 156.7% | Transportation | ||
RNAZ | US$2.52 | -73.1% | -89.2% | US$2.3m | US$20.00 | PB1.1x | S74.7% | n/a | Pharmaceuticals & Biotech | ||
BDRX | US$3.33 | -10.2% | -90.2% | US$2.3m | US$18.05 | PS21.3x | S-97.7% | n/a | Pharmaceuticals & Biotech |